These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 30958584)

  • 1. Regulation of insulin resistance by targeting the insulin-like growth factor 1 receptor with microRNA-122-5p in hepatic cells.
    Dong L; Hou X; Liu F; Tao H; Zhang Y; Zhao H; Song G
    Cell Biol Int; 2019 May; 43(5):553-564. PubMed ID: 30958584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-351 eases insulin resistance and liver gluconeogenesis via the PI3K/AKT pathway by inhibiting FLOT2 in mice of gestational diabetes mellitus.
    Chen SH; Liu XN; Peng Y
    J Cell Mol Med; 2019 Sep; 23(9):5895-5906. PubMed ID: 31287224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
    Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
    Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA X-inactive specific transcript (lncRNA XIST) inhibits hepatic insulin resistance by competitively binding microRNA-182-5p.
    Zhong G; Yang Q; Wang Y; Liang Y; Wang X; Zhao D
    Immun Inflamm Dis; 2023 Nov; 11(11):e969. PubMed ID: 38018594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-503 regulates hypoxia-induced cardiomyocytes apoptosis through PI3K/Akt pathway by targeting IGF-1R.
    Zhu W; Lei J; Bai X; Wang R; Ye Y; Bao J
    Biochem Biophys Res Commun; 2018 Dec; 506(4):1026-1031. PubMed ID: 30404731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of microRNA-223 promotes degranulation via the PI3K/Akt pathway by targeting IGF-1R in mast cells.
    Wang Q; Zhao DY; Xu H; Zhou H; Yang QY; Liu F; Zhou GP
    PLoS One; 2015; 10(4):e0123575. PubMed ID: 25875646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-455-5p suppresses hepatocellular carcinoma cell growth and invasion via IGF-1R/AKT/GLUT1 pathway by targeting IGF-1R.
    Hu Y; Yang Z; Bao D; Ni JS; Lou J
    Pathol Res Pract; 2019 Dec; 215(12):152674. PubMed ID: 31732382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-499-5p Contributes to Hepatic Insulin Resistance by Suppressing PTEN.
    Wang L; Zhang N; Pan HP; Wang Z; Cao ZY
    Cell Physiol Biochem; 2015; 36(6):2357-65. PubMed ID: 26279439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-138-5p affects insulin resistance to regulate type 2 diabetes progression through inducing autophagy in HepG2 cells by regulating SIRT1.
    Luan B; Sun C
    Nutr Res; 2018 Nov; 59():90-98. PubMed ID: 30442237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-451 Negatively Regulates Hepatic Glucose Production and Glucose Homeostasis by Targeting Glycerol Kinase-Mediated Gluconeogenesis.
    Zhuo S; Yang M; Zhao Y; Chen X; Zhang F; Li N; Yao P; Zhu T; Mei H; Wang S; Li Y; Chen S; Le Y
    Diabetes; 2016 Nov; 65(11):3276-3288. PubMed ID: 27495223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NFE2 Induces miR-423-5p to Promote Gluconeogenesis and Hyperglycemia by Repressing the Hepatic FAM3A-ATP-Akt Pathway.
    Yang W; Wang J; Chen Z; Chen J; Meng Y; Chen L; Chang Y; Geng B; Sun L; Dou L; Li J; Guan Y; Cui Q; Yang J
    Diabetes; 2017 Jul; 66(7):1819-1832. PubMed ID: 28411267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-185-5p inhibits hepatic gluconeogenesis and reduces fasting blood glucose levels by suppressing G6Pase.
    Zheng H; Wan J; Shan Y; Song X; Jin J; Su Q; Chen S; Lu X; Yang J; Li Q; Song Y; Li B
    Theranostics; 2021; 11(16):7829-7843. PubMed ID: 34335967
    [No Abstract]   [Full Text] [Related]  

  • 13. IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway.
    Matà R; Palladino C; Nicolosi ML; Lo Presti AR; Malaguarnera R; Ragusa M; Sciortino D; Morrione A; Maggiolini M; Vella V; Belfiore A
    Oncotarget; 2016 Feb; 7(7):7683-700. PubMed ID: 26655502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. lncRNA MEG3 promotes hepatic insulin resistance by serving as a competing endogenous RNA of miR-214 to regulate ATF4 expression.
    Zhu X; Li H; Wu Y; Zhou J; Yang G; Wang W
    Int J Mol Med; 2019 Jan; 43(1):345-357. PubMed ID: 30431065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease.
    Liu X; Chen S; Zhang L
    Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E34-E42. PubMed ID: 32228319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor-1 receptor is regulated by microRNA-133 during skeletal myogenesis.
    Huang MB; Xu H; Xie SJ; Zhou H; Qu LH
    PLoS One; 2011; 6(12):e29173. PubMed ID: 22195016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. circMAP3K4 regulates insulin resistance in trophoblast cells during gestational diabetes mellitus by modulating the miR-6795-5p/PTPN1 axis.
    Du R; Wu N; Bai Y; Tang L; Li L
    J Transl Med; 2022 Apr; 20(1):180. PubMed ID: 35449053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of miR-497 induces hepatic insulin resistance in E3 rats with HFD-MetS by targeting insulin receptor.
    Wang X; Wang M; Li H; Lan X; Liu L; Li J; Li Y; Li J; Yi J; Du X; Yan J; Han Y; Zhang F; Liu M; Lu S; Li D
    Mol Cell Endocrinol; 2015 Nov; 416():57-69. PubMed ID: 26300412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-520b Inhibits IGF-1R to Increase Doxorubicin Sensitivity and Promote Cell Apoptosis in Breast Cancer.
    Zhang H; Zheng XD; Zeng XH; Li L; Zhou Q
    Yakugaku Zasshi; 2021 Mar; 141(3):415-426. PubMed ID: 33116033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic miR-125b inhibits insulin signaling pathway by targeting PIK3CD.
    Du X; Li X; Chen L; Zhang M; Lei L; Gao W; Shi Z; Dong Y; Wang Z; Li X; Liu G
    J Cell Physiol; 2018 Aug; 233(8):6052-6066. PubMed ID: 29319168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.